JP2021526547A5 - - Google Patents
Info
- Publication number
- JP2021526547A5 JP2021526547A5 JP2021510540A JP2021510540A JP2021526547A5 JP 2021526547 A5 JP2021526547 A5 JP 2021526547A5 JP 2021510540 A JP2021510540 A JP 2021510540A JP 2021510540 A JP2021510540 A JP 2021510540A JP 2021526547 A5 JP2021526547 A5 JP 2021526547A5
- Authority
- JP
- Japan
- Prior art keywords
- complex carbohydrate
- vaccine composition
- protein antigen
- sequence
- complex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024002863A JP7833736B2 (ja) | 2018-05-03 | 2024-01-11 | 複合糖質ワクチン |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1807303.1 | 2018-05-03 | ||
| GBGB1807303.1A GB201807303D0 (en) | 2018-05-03 | 2018-05-03 | Glyconjugate vaccines |
| PCT/EP2019/061266 WO2019211386A1 (en) | 2018-05-03 | 2019-05-02 | Glyconjugate vaccines |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024002863A Division JP7833736B2 (ja) | 2018-05-03 | 2024-01-11 | 複合糖質ワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021526547A JP2021526547A (ja) | 2021-10-07 |
| JP2021526547A5 true JP2021526547A5 (enExample) | 2022-04-26 |
| JP7511188B2 JP7511188B2 (ja) | 2024-07-05 |
Family
ID=62598278
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510540A Active JP7511188B2 (ja) | 2018-05-03 | 2019-05-02 | 複合糖質ワクチン |
| JP2024002863A Active JP7833736B2 (ja) | 2018-05-03 | 2024-01-11 | 複合糖質ワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024002863A Active JP7833736B2 (ja) | 2018-05-03 | 2024-01-11 | 複合糖質ワクチン |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12048743B2 (enExample) |
| EP (1) | EP3787675A1 (enExample) |
| JP (2) | JP7511188B2 (enExample) |
| CN (2) | CN119454925A (enExample) |
| GB (1) | GB201807303D0 (enExample) |
| WO (1) | WO2019211386A1 (enExample) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5057540A (en) | 1987-05-29 | 1991-10-15 | Cambridge Biotech Corporation | Saponin adjuvant |
| NZ230747A (en) | 1988-09-30 | 1992-05-26 | Bror Morein | Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina |
| CA2017507C (en) | 1989-05-25 | 1996-11-12 | Gary Van Nest | Adjuvant formulation comprising a submicron oil droplet emulsion |
| AUPM873294A0 (en) | 1994-10-12 | 1994-11-03 | Csl Limited | Saponin preparations and use thereof in iscoms |
| SE0202110D0 (sv) | 2002-07-05 | 2002-07-05 | Isconova Ab | Iscom preparation and use thereof |
| SE0301998D0 (sv) | 2003-07-07 | 2003-07-07 | Isconova Ab | Quil A fraction with low toxicity and use thereof |
| GB0421083D0 (en) * | 2004-09-22 | 2004-10-27 | Glaxosmithkline Biolog Sa | Purification process |
| CN101983070B (zh) | 2008-02-20 | 2016-03-30 | 格林考瓦因有限公司 | 由来源于原核细胞的重组n-糖基化蛋白制备生物共轭物 |
| WO2010141312A2 (en) * | 2009-06-01 | 2010-12-09 | Wake Forest University Health Sciences | Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same |
| WO2012117377A1 (en) | 2011-03-02 | 2012-09-07 | Novartis Ag | Combination vaccines with lower doses of antigen and/or adjuvant |
| US9040057B2 (en) * | 2011-09-25 | 2015-05-26 | Chang Gung Medical Foundation, Linkou Branch | Method of diagnosing and preventing pneumococcal diseases using pneumococcal neuraminidases |
| JP2015510872A (ja) * | 2012-03-07 | 2015-04-13 | ノバルティス アーゲー | Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ抗原の増強された製剤 |
| GB201301085D0 (en) | 2013-01-22 | 2013-03-06 | London School Hygiene & Tropical Medicine | Glycoconjugate Vaccine |
| US11576958B2 (en) * | 2013-02-07 | 2023-02-14 | Children's Medical Center Corporation | Protein antigens that provide protection against pneumococcal colonization and/or disease |
| GB201610599D0 (en) | 2016-06-17 | 2016-08-03 | Glaxosmithkline Biologicals Sa | Immunogenic Composition |
-
2018
- 2018-05-03 GB GBGB1807303.1A patent/GB201807303D0/en not_active Ceased
-
2019
- 2019-05-02 WO PCT/EP2019/061266 patent/WO2019211386A1/en not_active Ceased
- 2019-05-02 EP EP19729443.2A patent/EP3787675A1/en active Pending
- 2019-05-02 CN CN202411403758.XA patent/CN119454925A/zh active Pending
- 2019-05-02 CN CN201980029219.5A patent/CN112384240B/zh active Active
- 2019-05-02 JP JP2021510540A patent/JP7511188B2/ja active Active
- 2019-05-02 US US17/052,485 patent/US12048743B2/en active Active
-
2024
- 2024-01-11 JP JP2024002863A patent/JP7833736B2/ja active Active
- 2024-06-13 US US18/742,842 patent/US12472249B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019338473B2 (en) | Multivalent pneumococcal vaccines | |
| Wizemann et al. | Adhesins as targets for vaccine development | |
| JP4848552B2 (ja) | 変異型ニューモリシンタンパク質 | |
| EP2241625A1 (en) | Proteinase K resistant surface protein of neisseria meningitidis | |
| JP2022514704A5 (enExample) | ||
| JP2010011868A5 (enExample) | ||
| JP2006506989A5 (enExample) | ||
| AR040922A1 (es) | Composicion inmunogenica multivalente, uso de la misma para la fabricacion de un medicamento y procedimiento para preparar dicha composicion inmunogenica multivalente | |
| JP2010508276A5 (enExample) | ||
| RU2002117308A (ru) | 85 кДа АНТИГЕН NEISSERIA | |
| JP2023531059A (ja) | 肺炎桿菌ｏ抗原ワクチン | |
| JP2025032259A (ja) | Ｏ結合型グリコシル化認識モチーフ | |
| JP2014507142A5 (enExample) | ||
| JP5744842B2 (ja) | 髄膜炎菌と肺炎球菌との結合型ワクチン及びそれを使用する方法 | |
| CN105111288A (zh) | 鲍曼不动杆菌亚单位疫苗抗原蛋白与应用 | |
| Khan et al. | Immunogenicity and protective efficacy of DnaJ (hsp40) of Streptococcus pneumoniae against lethal infection in mice | |
| JP2012524099A5 (enExample) | ||
| CN116063548A (zh) | 一种融合蛋白KP-Ag1及其用作肺炎克雷伯菌疫苗抗原的应用 | |
| Kilian | Streptococcus and enterococcus | |
| JP2021526547A5 (enExample) | ||
| KR20120010906A (ko) | ｐｅｐ27 유전자 돌연변이를 포함하는 약독화된 폐렴구균 균주 및 이의 용도 | |
| CN105497884B (zh) | 外膜蛋白Omp22作为鲍曼不动杆菌疫苗靶点的应用 | |
| CN102203122A (zh) | 用于预防β-溶血链球菌(BHS)疾病的多组分免疫原性组合物 | |
| WO2022101745A3 (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
| WO2018149216A1 (zh) | 肺炎链球菌疫苗 |